Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study

Author:

Kuruvilla John1ORCID,Armand Philippe2,Hamadani Mehdi3,Kline Justin4,Moskowitz Craig H.5,Avigan David6,Brody Joshua D.7ORCID,Ribrag Vincent8,Herrera Alex F.9,Morschhauser Franck10ORCID,Kanate Abraham11,Zinzani Pier Luigi1213,Bitran Jacob14,Ghesquieres Herve15ORCID,Schuster Stephen J.16,Farooqui Mohammed17,Marinello Patricia17,Bartlett Nancy L.18ORCID

Affiliation:

1. Princess Margaret Cancer Centre, Toronto, Canada

2. Dana-Farber Cancer Institute, Boston, MA, USA

3. Medical College of Wisconsin, Milwaukee, WI, USA

4. Department of Medicine, University of Chicago, Chicago, IL, USA

5. Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA

6. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

7. Icahn School of Medicine at Mount Sinai, New York, NY, USA

8. Gustave Roussy, Villejuif, France

9. City of Hope, Duarte, CA, USA

10. Department of Hematology, CHU Lille, Lille University, Lille, France

11. HonorHealth Cancer Transplant Institute, Scottsdale, AZ, USA

12. IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy

13. Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy

14. Advocate Lutheran General Hospital, Park Ridge, IL, USA

15. Lyon-Sud Hospital Center, Lyon, France

16. Department of Medicine, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

17. Merck & Co., Inc., Rahway, NJ, USA

18. Siteman Cancer Center, Washington University, St. Louis, MO, USA

Funder

Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Reference38 articles.

1. American Cancer Society. Types of B-cell lymphoma. Atlanta (GA): American Cancer Society; 2019 [updated 2019 Jan 29; cited 2021 Mar 15]. Available from: https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/b-cell-lymphoma.html

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines for Clinical Oncology. Small cell lung cancer. Version 2.2021. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2021 [updated 2021 Jan 11; cited 2021 Jan 25]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf

3. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

4. Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era

5. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3